摘要
目的:评价和比较同步放化疗与序贯治疗对中晚期鼻咽癌听觉功能的影响。方法:44例中晚期鼻咽癌患者随机分入同步治疗组和序贯治疗组。两组患者均在放疗前、放疗开始后1月和放疗结束后(1个月、3个月、6个月、12个月)检查纯音听阈和鼓室导抗图。结果:同步治疗组患者的听力损害大于序贯治疗组(P〈0.05)。放疗后1个月同步治疗组患者的语频(0.5~4.0kHz)和高频(8kHz)平均骨导听阈较治疗前分别提高7.2dB和25.5dB,而序贯治疗组分别提高了15.2dB和36.8dB,两组差异有统计学意义(P〈0.05)。结论:同步治疗组患者的听力损害较序贯治疗组发生早、发生率高、程度重。
Objective:To evaluate the effect of radiotherapy combined with synchronous chemotherapy on auditory function of patients with nasopharyngeal carcinoma. Methods:Forty-four patients with advanced nasopharyngeal carcinoma were divided into synchronous group and sequential group randomly. They were examined for pure-tone threshold average and tympanometry before and after therapy. Results: Auditory of patients in the synchronous group decreased more than sequential group ( P 〈 0. 05 ). One month after RT, there were 7. 2 dB and 25.5 dB increased in mean bone conduction ( BC )thresholds at speech (0. 5 -4.0 kHz)and high frequency (8.0 kHz)in the synchronous group,and there were 15.2 dB and 36. 8 dB increased in mean BC thresholds at speech and high frequency in the sequential group (P 〈 0. 05 ). Conclusion:The hearing impairment starts soon after radiotherapy combined with synchronous chemotherapy. The incidence and the extent of hearing loss of patients in the synchronous group are more than sequential group.
出处
《临床肿瘤学杂志》
CAS
2007年第5期376-378,共3页
Chinese Clinical Oncology
关键词
鼻咽癌
听觉功能
放化疗同步治疗
序贯治疗
Nasopharyngeal carcinoma
Auditory function
Chemo-radiotherapy concomitant therapy
Sequential therapy